Paratek Pharmaceuticals I... (PRTK)
NASDAQ: PRTK
· Real-Time Price · USD
2.23
0.04 (1.83%)
At close: Sep 20, 2023, 10:00 PM
Paratek Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 42.69M | 45.03M | 34.25M | 27.09M | 39.51M | 49.03M | 80.37M | 111M | 75.3M | 103.45M |
Short-Term Investments | n/a | n/a | n/a | 29.92M | 29.89M | 30.02M | 15.11M | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 37.54M | 36.74M | 32.47M | 33.36M | 33.03M | 33.75M | 28.39M | 25.82M | 22.18M | 13.87M |
Receivables | 42.51M | 37.17M | 78.04M | 32.74M | 31.82M | 28.26M | 33.12M | 22.13M | 60.81M | 18.54M |
Inventory | 11.41M | 13.99M | 16.57M | 20.75M | 13.08M | 12.73M | 11.02M | 8.82M | 7.95M | 14.21M |
Other Current Assets | 8.49M | 14.71M | 7.87M | 10.84M | 13.48M | 12.99M | 12.36M | 10.93M | 9.32M | 5.21M |
Total Current Assets | 105.23M | 111.01M | 136.84M | 121.34M | 127.77M | 133.28M | 152.1M | 153.01M | 153.5M | 141.83M |
Property-Plant & Equipment | 2.2M | 2.24M | 2.4M | 1.79M | 2.06M | 2.3M | 2.55M | 2.69M | 3.07M | 2.74M |
Goodwill & Intangibles | 829K | 829K | 829K | 829K | 829K | 829K | 829K | 829K | 829K | 829K |
Total Long-Term Assets | 40.56M | 39.81M | 35.7M | 35.98M | 35.93M | 36.88M | 31.77M | 29.34M | 26.08M | 17.45M |
Total Assets | 145.79M | 150.83M | 172.54M | 157.32M | 163.69M | 170.16M | 183.87M | 182.35M | 179.59M | 159.28M |
Account Payables | 2.95M | 5.32M | 5.31M | 8.11M | 2.26M | 4.7M | 5.39M | 4.99M | 2.59M | 4.04M |
Deferred Revenue | 34.8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 164.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 823K | 27.43M | 32.08M | 30.87M | 27.84M | 24.14M | 25.9M | 24.16M | 18.39M | 18.91M |
Total Current Liabilities | 202.62M | 32.74M | 37.39M | 38.98M | 30.1M | 28.84M | 31.3M | 29.15M | 20.98M | 22.96M |
Long-Term Debt | 95.71M | 259.07M | 258.41M | 259.1M | 258.01M | 257.01M | 255.74M | 254.66M | 254.46M | 252.25M |
Other Long-Term Liabilities | 48.82M | 48.05M | 47.78M | 25.39M | 24.95M | 24.61M | 24.62M | 3.53M | 3.44M | 3.08M |
Total Long-Term Liabilities | 144.54M | 307.12M | 306.19M | 284.5M | 282.96M | 281.62M | 280.36M | 258.19M | 257.9M | 255.33M |
Total Liabilities | 347.16M | 339.87M | 343.58M | 323.47M | 313.06M | 310.46M | 311.66M | 287.34M | 278.88M | 278.29M |
Total Debt | 259.76M | 259.07M | 258.41M | 259.1M | 258.01M | 257.01M | 255.74M | 254.66M | 254.46M | 252.25M |
Common Stock | 57K | 57K | 56K | 55K | 55K | 53K | 52K | 50K | 48K | 47K |
Retained Earnings | -965.14M | -950.59M | -930.45M | -923.29M | -902.41M | -884.79M | -866.88M | -834.63M | -816.43M | -826.14M |
Comprehensive Income | n/a | n/a | n/a | -117K | -233K | -180K | -9K | n/a | n/a | n/a |
Shareholders Equity | -201.37M | -189.04M | -171.04M | -166.15M | -149.37M | -140.3M | -127.79M | -104.99M | -99.29M | -119.01M |
Total Investments | n/a | n/a | n/a | 29.92M | 29.89M | 30.02M | 15.11M | n/a | n/a | n/a |